CRISPR/Cas9: Role of genome editing in cancer immunotherapy

S. Vimal; Inamul Hasan Madar; Logalakshmi Thirumani; Lakshmi Thangavelu; Azhagu Madhavan Sivalingam

doi:10.1016/j.oor.2024.100251

CRISPR/Cas9: Role of genome editing in cancer immunotherapy

S. Vimal
, Inamul Hasan Madar
, Logalakshmi Thirumani
, Lakshmi Thangavelu
, Azhagu Madhavan Sivalingam

Saveetha Institute of Medical and Technical Sciences (Deemed to be University)

Research output: Contribution to journal › Letter › peer-review

14 Scopus citations

Original language	English
Article number	100251
Journal	Oral Oncology Reports
Volume	10
DOIs	https://doi.org/10.1016/j.oor.2024.100251
State	Published - Jun 2024
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

CRISPR/Cas9
Gene therapy
Genome editing
Immunotherapy

Access to Document

10.1016/j.oor.2024.100251

Cite this

@article{c70bf97e288d47a6ba5cf3c4a9df1aa8,

title = "CRISPR/Cas9: Role of genome editing in cancer immunotherapy",

keywords = "CRISPR/Cas9, Gene therapy, Genome editing, Immunotherapy",

author = "S. Vimal and Madar, \{Inamul Hasan\} and Logalakshmi Thirumani and Lakshmi Thangavelu and Sivalingam, \{Azhagu Madhavan\}",

year = "2024",

month = jun,

doi = "10.1016/j.oor.2024.100251",

language = "English",

volume = "10",

journal = "Oral Oncology Reports",

issn = "2772-9060",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - CRISPR/Cas9

T2 - Role of genome editing in cancer immunotherapy

AU - Vimal, S.

AU - Madar, Inamul Hasan

AU - Thirumani, Logalakshmi

AU - Thangavelu, Lakshmi

AU - Sivalingam, Azhagu Madhavan

PY - 2024/6

Y1 - 2024/6

KW - CRISPR/Cas9

KW - Gene therapy

KW - Genome editing

KW - Immunotherapy

UR - https://www.scopus.com/pages/publications/85189512376

U2 - 10.1016/j.oor.2024.100251

DO - 10.1016/j.oor.2024.100251

M3 - Letter

AN - SCOPUS:85189512376

SN - 2772-9060

VL - 10

JO - Oral Oncology Reports

JF - Oral Oncology Reports

M1 - 100251

ER -

CRISPR/Cas9: Role of genome editing in cancer immunotherapy

UN SDGs

Keywords

Access to Document

Other files and links

Cite this